A group-based transdiagnostic sleep and circadian treatment for major depressive disorder: A randomized controlled trial.

Anneko Yuen-Yum YauKa-Yan NgWing-Yin LauChun-Yin PoonWing-Fai YeungKa-Fai ChungChristian S ChanAllison G HarveyFiona Yan Yee Ho

Published in: Journal of consulting and clinical psychology (2024)

TranS-C was efficacious and acceptable in alleviating depressive symptoms and sleep and circadian disruptions in adults with MDD. The group format appears to be a low-cost, widely disseminable option to deliver TranS-C. Further research on TranS-C to examine its benefits on other psychiatric disorders is warranted. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Keyphrases

major depressive disorder
low cost
bipolar disorder
depressive symptoms
sleep quality
physical activity
social support
emergency department
adverse drug
replacement therapy